Skip to main content
SpringerLink
Log in

Management of brain metastases from breast cancer by combination chemotherapy

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Summary

Since most patients with brain metastases from breast cancer have disseminated disease elsewhere and a dismal prognosis when treated by whole brain irradiation alone, we investigated the use of systemic chemotherapy in 66 such patients. Fifty-two percent (34 of 66 patients) demonstrated an objective response to this therapy which was similar to the results obtained in patients treated for extracranial metastases. Eighteen patients who subsequently had recurrence of brain metastases were successfully retreated with secondary chemotherapy. The median duration of remission in 34 responders was ten months. The median survival, from the time of chemotherapy for brain metastases, was 13.1 months in 34 responders (range 5–74+) vs. 3.0 months in 32 non-responders (P < 0.001).

These findings suggest that systemic chemotherapy is effective in the treatment of patients with brain metastases from breast cancer by inducing remission and prolonging survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lang EF, Slater J: Metastatic brain tumor: Results of surgical and nonsurgical treatment. Surg Clin North Am 44:865–872, 1964.

    Google Scholar 

  2. Posner JB: Management of central nervous system metastases. Semin Oncol 4:81–91, 1977.

    Google Scholar 

  3. Order SE, Heilman S, Von Essen CF, Kligerman MH: Improvement in quality of survival following whole-brain irradiation for brain metastases. Radiology 91:149–153, 1968.

    Google Scholar 

  4. Horton J, Baxter DH, Olson KB: The management of metastases to the brain by irradiation and corticosteroids. Am J Roentgenol 3:334–336, 1971.

    Google Scholar 

  5. Nisce LZ, Hilaris BS, Chu FC: A review of experience with irradiation of brain metastases. Am J Roentgenol 3:329–333, 1971.

    Google Scholar 

  6. Wilson CB: Brain metastases: The basis for surgical selection. Int J Rad Oncol Biol Phys 2:169–197, 1977.

    Google Scholar 

  7. Montana GS, Meacham WF, Caldwell WL: Brain irradiation for metastatic disease of lung origin. Cancer 29:1477–1480, 1972.

    Google Scholar 

  8. Hendrickson FR: The optimum schedule for palliative radiotherapy for metastatic brain. cancer. Int J Rad Oncol Biol Phys 2:165–168, 1977.

    Google Scholar 

  9. Casimir M, Yap HY, Distefano A, Hortobagyi GN, Blumenshein GR: The influence of combined modality treatment on the survival of breast cancer patients with brain metastases. Proc Am Soc Clin Oncol (ASCO) 22:442, 1981 (abstract).

    Google Scholar 

  10. Logothetis CJ, Samuels ML, Trindale A: The management of brain metastases in germ cell tumors. Cancer 49:12–18, 1982.

    Google Scholar 

  11. Vick NA, Bigner DD: Microvascular abnormalities in virally-induced canine brain tumors: Structural bases for altered blood-brain barrier function. J Neurol Sci 17:29–39, 1972.

    Google Scholar 

  12. Vick NA, Khandekar JD, Bigner DD: Chemotherapy of brain tumors: the ‘blood-brain barrier’ is not a factor. Arch Neurol 34:523–526, 1977.

    Google Scholar 

  13. Bourke RS, West CR, Cheda G, Tower DB: Kinetics of entry and distribution of 5-fluorouracil in cerebrospinal fluid and brain following intravenous injection in a primate. Cancer Res 33:1735–1746, 1973.

    Google Scholar 

  14. Carey RW, Davis JM, Zervas NT: Tamoxifen-induced regression of cerebral metastasis in breast carcinoma. Cancer Treat Rep 65:793–795, 1981.

    Google Scholar 

  15. Hayward JL, Rubens RD, Carbone PP, Heuson JC, Kumaoka S, Segaloff A: Assessment of response to therapy in advanced breast cancer. Br J Cancer 35:292–298, 1977.

    Google Scholar 

  16. Rosner D, Sneyderman M, Nemoto T: Potentiating role of previously administered agents in the combination chemotherapy of breast cancer. Oncology 36:160–163, 1979.

    Google Scholar 

  17. Rosner D, Nemoto T: Sequence for developing optimal combination chemotherapy of metastatic breast cancer. Eur J Cancer 15:1197–1201, 1979.

    Google Scholar 

  18. Hirano A, Matsui T: Vascular structures in brain tumors. Hum Pathol 6:611–621, 1975.

    Google Scholar 

  19. Waggener JD, Beggs JL: Vasculature of neural neoplasms. Adv Neurol 15:27–49, 1976.

    Google Scholar 

  20. Alen FP, Edelman FL, Katzman R, Scheinberg LC: Ultrastructural and biochemical analysis in cerebral edema associated with experimental mouse gliomas. J Neuropathol Exp Neurol 23:253–263, 1964.

    Google Scholar 

  21. Raimondi AJ, Mullan S, Evans JP: Human brain tumors, an electronmicroscopic study. J Neurosurg 19:731–753, 1962.

    Google Scholar 

  22. Tator CH, Morley TP, Olszewski J: A study of the factors responsible for the accumulation of radioactive iodinated serum albumin (RISA) by intracranial tumors and other lesions. J Neurosurg 22:60–76, 1965.

    Google Scholar 

  23. Wright RL: Neovascularization in experimental gliomas. J Neuropathol Exp Neurol 22:435–445, 1963.

    Google Scholar 

  24. Wright RL: Vascular permeability in experimental brain tumors. Angiology 18:69–75, 1967.

    Google Scholar 

  25. Hasegawa H, Shapiro WS, Posner JB: Chemotherapy of experimental metastatic brain tumors in female wistar rats. Cancer Res 39:2691–2697, 1979.

    Google Scholar 

  26. Levin VA, Chadwick M, Little AD: Distribution of 5-fluorouracil-2-14C and its metabolites in a murine glioma. J Natl Cancer Inst 49:1577–1584, 1972.

    Google Scholar 

  27. Mukherjee KL, Curreri AR, Javid M, Heidelberger C: Studies on fluorinated pyrimidines XVIL Tissue distribution of 5-fluorouracil-2-C14 and 5-Fluoro-2′-deoxyuridine in cancer patients. Cancer Res 23:67–77, 1963.

    Google Scholar 

  28. Ushio Y, Posner JB, Shapiro WR: Chemotherapy of experimental meningeal carcinomatosis. Cancer Res 37:1232–1237, 1977.

    Google Scholar 

  29. Hildebrand J, Brihaye J, Wagenknecht L, Michel J, Kenis Y: Combination chemotherapy with CCNU, vincristine and methotrexate in primary and metastatic brain tumors. Eur J Cancer 11:585–587, 1975.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Breast Surgery, Pathology, and Computer Center, Roswell Park Memorial Institute, 14263, Buffalo, NY, USA

    Dutzu Rosner M.D., Takuma Nemoto, John Pickren & Warren Lane

Authors
  1. Dutzu Rosner M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takuma Nemoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. John Pickren
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Warren Lane
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rosner, D., Nemoto, T., Pickren, J. et al. Management of brain metastases from breast cancer by combination chemotherapy. J Neuro-Oncol 1, 131–137 (1983). https://doi.org/10.1007/BF00182958

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00182958

Keywords

Search

Navigation